hims weight loss - Search News

Hims & hers health, food and drug administration

Reuters on MSN · 2d

Hims & Hers to sell Lilly's weight-loss drug on its telehealth platform (April 1)

Shares of Hims & Hers closed 5.1% higher after the company said it will expand its weight-loss offerings with branded versions of Lilly's tirzepatide — the active ingredient in weight-loss drug Zepbound and diabetes medicine Mounjaro — and generics of Novo's diabetes drug,

The Wall Street Journal on MSN · 2d

Hims & Hers Expands Weight Loss Offering, Adds Lilly’s Zepbound to Platform

The telehealth-consultation platform said it plans to continue expanding its weight loss offerings.

Investopedia on MSN · 2d

Hims & Hers Stock Surges as Telehealth Platform Adds Eli Lilly Weight-Loss Drugs

Hims & Hers Health shares jumped Tuesday as the company added Eli Lilly’s weight-loss drug Zepbound and diabetes treatment Mounjaro to its telehealth platform.

2d

Zepbound Now Available Through Hims & Hers

Zepbound is made by drugmaker Eli Lilly. While Hims & Hers offers it for $1,899 per month, Lilly said the price on its own ...

Modern Healthcare2d

Eli Lilly denies affiliation with Hims & Hers

Eli Lilly quickly disassociated itself from Hims & Hers after the telehealth company said it was selling the pharmaceutical ...

2d

‘Too Hot to Handle,’ Analyst Warning on Hims & Hers Health Stock (HIMS)

Telehealth platform Hims & Hers Health, Inc. (HIMS), which connects consumers to healthcare professionals, is at a crossroads ...

2don MSN

Why Hims & Hers Health Stock Soared Tuesday

Shares of Hims & Hers Health ( HIMS 5.01%) surged on Tuesday, closing the session up 5.25% after having been up by as much as ...

1d

Analysts Stay Cautious on HIMS Stock amid Core Business Uncertainty

Hims & Hers Health Inc. (HIMS) is facing increased skepticism from investors and analysts over the sustainability concerns of ...

1d

‘Hold the Phone,’ Says Morgan Stanley on Hims & Hers Health Stock (HIMS)

Hims & Hers Health (HIMS) is trying its best to stay relevant in the multi-billion dollar obesity treatment market. Despite a ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results